Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Chronic Liver Failure

fluorodeoxyglucose f18 has been researched along with Chronic Liver Failure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonino, AT; Blagosklonov, O; Bresson-Hadni, S; Brientini, MP; Delabrousse, E; Gillet, M; Grenouillet, F; Ito, A; Knapp, J; Mantion, GA; Minello, A; Richou, C; Sako, Y; Vuitton, DA1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Chronic Liver Failure

ArticleYear
Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011, Volume: 17, Issue:7

    Topics: Adult; Benzimidazoles; Echinococcosis; Echinococcosis, Hepatic; End Stage Liver Disease; Female; Fluorodeoxyglucose F18; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome

2011